GlaxoSmithKline plc (ADR) (NYSE:GSK)

CAPS Rating: 4 out of 5

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

Recs

0
Player Avatar RetiredAt37 (54.39) Submitted: 5/4/2011 9:03:19 AM : Outperform Start Price: $41.31 GSK Score: +9.81

Basic value play

Featured Broker Partners


Advertisement